StocksMedium•8 October 2026•
1 min read
PhRMA Lobby Sues Trump Administration Over Medicare Drug Pricing Rule
Key Facts
1The PhRMA lobby group sued the Trump administration over its Medicare drug pricing rule, calling it an unlawful overreach.
The PhRMA lobby group sued the Trump administration over its Medicare drug pricing rule. Benzinga reported that the pharmaceutical group called the regulation an unlawful overreach, filing a lawsuit to challenge the legality of the rules implemented by the Centers for Medicare & Medicaid Services (CMS).
The lobby group argues that CMS exceeded its authority under federal law and claims that the negotiation results were preordained. This legal challenge highlights ongoing friction between the pharmaceutical sector and regulatory policies, which could impact industry margins as litigation proceeds.